Ġordan - Ingliż - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة دار الدواء للتنمية والأستثمار - dar al dawa development and investment co ltd - clomifene citrate 50 mg - 50 mg

Kenja - Ingliż - Pharmacy and Poisons Board

national pharmacy ltd p.o box 17843-00500 nairobi, kenya - clomiphene citrate - tablet - 50mg - clomifene

Singapor - Ingliż - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - clomiphene citrate - tablet - 50 mg

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

orion pharma (aus) pty limited - toremifene citrate, quantity: 88.5 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; colloidal anhydrous silica; sodium starch glycollate; microcrystalline cellulose; magnesium stearate; povidone; maize starch - for the first line treatment of hormone-dependent metastatic breast cancer in postmenopausal women. it is not recommended for patients with oestrogen receptor negative tumours.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - tamoxifen citrate, quantity: 30.4 mg (equivalent: tamoxifen, qty 20 mg) - tablet, uncoated - excipient ingredients: magnesium stearate; croscarmellose sodium; maize starch; mannitol - treatment of breast cancer. genox is indicated for the treatment of breast cancer. primary reduction of breast cancer risk. genox is indicated for the primary reduction of breast cancer risk in women either at moderately increased risk (lifetime breast cancer risk 1.5 to 3 times the population average) or high risk (lifetime breast cancer risk greater than 3 times the population average).

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - tamoxifen citrate, quantity: 15.2 mg (equivalent: tamoxifen, qty 10 mg) - tablet, uncoated - excipient ingredients: maize starch; magnesium stearate; croscarmellose sodium; mannitol - treatment of breast cancer. genox is indicated for the treatment of breast cancer. primary reduction of breast cancer risk. genox is indicated for the primary reduction of breast cancer risk in women either at moderately increased risk (lifetime breast cancer risk 1.5 to 3 times the population average) or high risk (lifetime breast cancer risk greater than 3 times the population average).

Baħrajn - Ingliż - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

hashim pharmacy - clomifene citrate - tablet - 50

Baħrajn - Ingliż - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

wael pharmacy - clomifene citrate - tablet - 50

Ġappun - Ingliż - すりの適正使用協議会 RAD-AR Council, Japan

fuji pharmaceutical co.,ltd. - clomifene citrate - white tablet, diameter: 9.0 mm, thickness: 4.1 mm

Panama - Ingliż - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios recalcine, s.a . - clomifeno citrato - clomifeno citrato....50.000 mg